These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19738411)

  • 1. Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression.
    Nierenberg AA
    Psychother Psychosom; 2009; 78(6):391-3. PubMed ID: 19738411
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
    Gabbay V; O'Dowd MA; Asnis GM
    J Clin Psychiatry; 2002 Apr; 63(4):367; author reply 367-8. PubMed ID: 12000212
    [No Abstract]   [Full Text] [Related]  

  • 3. Bupropion in the treatment of bipolar disorders: the same old story?
    Fogelson DL; Bystritsky A; Pasnau R
    J Clin Psychiatry; 1992 Dec; 53(12):443-6. PubMed ID: 1487473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.
    Wright G; Galloway L; Kim J; Dalton M; Miller L; Stern W
    J Clin Psychiatry; 1985 Jan; 46(1):22-5. PubMed ID: 2856918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of buspirone and bupropion in the treatment of depression.
    Fava M
    Psychother Psychosom; 2007; 76(5):311-2. PubMed ID: 17700052
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible augmentation of antidepressant response by buspirone.
    Jacobsen FM
    J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind trial of bupropion versus desipramine for bipolar depression.
    Sachs GS; Lafer B; Stoll AL; Banov M; Thibault AB; Tohen M; Rosenbaum JF
    J Clin Psychiatry; 1994 Sep; 55(9):391-3. PubMed ID: 7929019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar depression: treatment options.
    Yatham LN; Kusumakar V; Parikh SV; Haslam DR; Matte R; Sharma V; Kennedy S
    Can J Psychiatry; 1997 Aug; 42 Suppl 2():87S-91S. PubMed ID: 9288441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making optimal use of combination pharmacotherapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2004; 65 Suppl 15():21-4. PubMed ID: 15554792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupropion as a promising approach to rapid cycling bipolar II patients.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1990 Nov; 51(11):450-5. PubMed ID: 2121720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing trends of antidepressants in bipolar depression.
    Zarate CA; Tohen M; Baraibar G; Kando JC; Mirin J
    J Clin Psychiatry; 1995 Jun; 56(6):260-4. PubMed ID: 7775368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the depressive component of bipolar disorder.
    Kalin NH
    Depress Anxiety; 1996-1997; 4(4):190-8. PubMed ID: 9166651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
    Papakostas GI; Petersen TJ; Perlis RH; Judy AE; Burns AM; Alpert JE; Birnbaum RJ; Fava M
    J Clin Psychopharmacol; 2006 Apr; 26(2):216-8. PubMed ID: 16633159
    [No Abstract]   [Full Text] [Related]  

  • 14. Organic mental disorders associated with bupropion in three patients.
    Ames D; Wirshing WC; Szuba MP
    J Clin Psychiatry; 1992 Feb; 53(2):53-5. PubMed ID: 1541606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for neuroleptics in bipolar depression?
    Hendrick V; Altshuler LL; Szuba MP
    J Clin Psychiatry; 1994 Dec; 55(12):533-5. PubMed ID: 7814347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
    Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
    Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients.
    Erfurth A; Michael N; Stadtland C; Arolt V
    Neuropsychobiology; 2002; 45 Suppl 1():33-6. PubMed ID: 11893875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin in mood disorders.
    Srinivasan V; Smits M; Spence W; Lowe AD; Kayumov L; Pandi-Perumal SR; Parry B; Cardinali DP
    World J Biol Psychiatry; 2006; 7(3):138-51. PubMed ID: 16861139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.